Searchable abstracts of presentations at key conferences in endocrinology

ea0056p304 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience

Navarro-Hoyas Clara , Moragrega Raquel Miralles , Delegido-Gomez Laura , Lopez-Munoz Beatriz , Moreno-Perez Oscar , Pico-Alfonso Antonio , Gonzalez-Sanchez Victor

Introduction: PCSK9 inhibitors (iPCSK9) have previously been evaluated through controlled clinical trials showing up to 60% reduction in LDL cholesterol concentrations. However, we still do not have enough data regarding the real life experience of the treatment.Objectives: 1) Describe patients with hypercholesterolemia treated with iPCSK9 in clinical practice.2) Evaluate treatment efficacy and safety.Methods...

ea0056p1170 | Thyroid cancer | ECE2018

Evolution of tumor markers after external beam radiotherapy in the non-undifferentiated thyroid cancer

Moragrega Raquel Miralles , Freixes Maria Maria Curras , Zelaya Carolina Perdomo , Vaamonde Javier Gargallo , Valero Maria Llavero , Jimenez Marta Moreno , Galofre Juan C

Introduction: The role of external beam radiotherapy (EBRT) as primary or as adjuvant therapy in the non-undifferentiated thyroid cancer (NUTC) is controversial. Most published data refer to retrospective case series. Therefore, little is known about the correlation between tumor markers and radiologic measurements of tumor response.Objectives: The study aimed to analyze the kinetics of tumor markers and radiologic measurement of tumor response after EBR...